Skip to Main Content

Author Details

Juan P Palazzo
Thomas Jefferson University Hospital
1988
193
58
PMIDPaper TitleJournal TitlePublished Year
36734633Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer.Cancer Discov2023
36652667High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.JCO Precis Oncol2023
36577093The Spectrum of Mucinous Lesions of the Breast.Arch Pathol Lab Med2023
36734633Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer.Cancer Discov2023
36652667High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.JCO Precis Oncol2023
36577093The Spectrum of Mucinous Lesions of the Breast.Arch Pathol Lab Med2023
31883913PD-L1 status in breast cancer: Current view and perspectives.Semin Cancer Biol2021
31883913PD-L1 status in breast cancer: Current view and perspectives.Semin Cancer Biol2021
32367460Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.Breast Cancer Res Treat2020
32197944Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.Clin Breast Cancer2020
32367460Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.Breast Cancer Res Treat2020
31896809Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.Mod Pathol2020
32279409Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases.Breast J2020
33112876APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.PLoS One2020
31896809Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.Mod Pathol2020
33112876APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.PLoS One2020
32279409Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases.Breast J2020
32197944Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.Clin Breast Cancer2020
30528798Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.Eur J Cancer2019
30268765Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.Clin Breast Cancer2019
30350269Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.Breast Cancer Res Treat2019
30528798Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.Eur J Cancer2019
30565349Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast.Breast J2019
30675516Assessment of <i>HMGA2</i> and <i>PLAG1</i> rearrangements in breast adenomyoepitheliomas.NPJ Breast Cancer2019
30716341Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.Hum Pathol2019
30716341Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.Hum Pathol2019
30350269Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.Breast Cancer Res Treat2019
30268765Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.Clin Breast Cancer2019
30675516Assessment of <i>HMGA2</i> and <i>PLAG1</i> rearrangements in breast adenomyoepitheliomas.NPJ Breast Cancer2019
30565349Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast.Breast J2019
29739933Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.Nat Commun2018
30072169STAT6 expression in spindle cell lesions of the breast: An immunohistochemical study of 48 cases.Pathol Res Pract2018
30166553Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.Nat Commun2018
30097435Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.Clin Cancer Res2018
30323088A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.J Natl Compr Canc Netw2018
29940288Utility of STAT6 and 13q14 deletion in the classification of the benign spindle cell stromal tumors of the breast.Hum Pathol2018
29739933Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.Nat Commun2018
30911223Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal Cancer.Biomark Cancer2018
29940288Utility of STAT6 and 13q14 deletion in the classification of the benign spindle cell stromal tumors of the breast.Hum Pathol2018
30072169STAT6 expression in spindle cell lesions of the breast: An immunohistochemical study of 48 cases.Pathol Res Pract2018
30097435Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.Clin Cancer Res2018
30166553Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.Nat Commun2018
30911223Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal Cancer.Biomark Cancer2018
30323088A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.J Natl Compr Canc Netw2018
27531819Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.J Clin Pathol2017
28467142Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.Radiology2017
28911083Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.Ann Oncol2017
28421181MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.Front Cell Dev Biol2017
28487386An miRNA Expression Signature for the Human Colonic Stem Cell Niche Distinguishes Malignant from Normal Epithelia.Cancer Res2017
27531819Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.J Clin Pathol2017
  • 1 - 50 of 386

Recommended Authors

Lina Irshaid
Pathology Associates at Beverly Hospital
Career Start Year 2017
Number of shared co-authors 0
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Joerg Schwock
University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 11
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 2
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 2
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 5
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 7
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 1
Christina S Kong
Stanford University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 6
Pedram Argani
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Gary L Keeney
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 2
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 7
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 10
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 5
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 2
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 0
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 9
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 6
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 2
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 6

Collaborators

Gordon F Schwartz
Thomas Jefferson University
Co-authored papers 16
Terry Hyslop
Co-authored papers 15
Bingshan Li
Co-authored papers 13
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 9
Charles M Perou
Co-authored papers 7
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 6
John Quackenbush
Harvard T. H. Chan School of Public Health
Co-authored papers 5
Zhaomei Mu
Thomas Jefferson University Hospital
Co-authored papers 5
Lifang Hou
Co-authored papers 4
Hie-Won Hann
Co-authored papers 4
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Joanne Xiu
Co-authored papers 4
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Paul H Duray
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 3
Cheng Fan
Co-authored papers 3
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 3
Ossama Tawfik
University of Kansas
Co-authored papers 3
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 3
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Dennis B Cornfield
Lehigh Valley Hospital
Co-authored papers 3
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Co-authored papers 2
Li Gong
Stanford University
Co-authored papers 2
Craig D Shriver
Walter Reed National Military Medical Center
Co-authored papers 2
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Matthew J Ellis
Co-authored papers 2
Lajos Pusztai
Co-authored papers 2
Release 1.2